Clinical Decision Support Systems Market (System - Knowledge-based Systems, Expert Laboratory Information System, and Machine Learning Systems; Mode of Advice - Passive CDSS, and Active CDSS; Application - Drug Databases, Care Plans, Disease Reference, and Others; Delivery Model - On-premise, Web-based, and Cloud-based; End-use - Diagnostic Centers, Hospitals, Clinics, Retail Pharmacy, and Diagnostic Decision Support): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Clinical Decision Support Systems Market (System - Knowledge-based Systems, Expert Laboratory Information System, and Machine Learning Systems; Mode of Advice - Passive CDSS, and Active CDSS; Application - Drug Databases, Care Plans, Disease Reference, and Others; Delivery Model - On-premise, Web-based, and Cloud-based; End-use - Diagnostic Centers, Hospitals, Clinics, Retail Pharmacy, and Diagnostic Decision Support): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

Report Code: IGR01305 Category: Healthcare & Medical Devices Published: October, 2023

A recent report published by Infinium Global Research on clinical decision support systems market provides in-depth analysis of segments and sub-segments in the global as well as regional clinical decision support systems market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional clinical decision support systems market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global clinical decision support systems market.

Market Insight:

The global clinical decision support systems market was valued at USD 4.43 billion in 2022 and is expected to reach USD 10.97 billion in 2030, with a CAGR of 10.42% during the forecast period 2023-2030.

Clinical Decision Support Systems (CDSS) is a segment of the healthcare industry, encompassing the development and deployment of sophisticated digital tools and software solutions. These solutions are purpose-built to aid healthcare professionals in making well-informed clinical decisions. CDSS harnesses the power of data analysis, medical expertise, and algorithms to deliver real-time recommendations, alerts, and insights to clinicians, ultimately enhancing patient care quality and safety. They play a pivotal role in elevating the overall quality of healthcare delivery, reducing medical errors, and optimizing resource utilization within healthcare facilities. The scope of CDSS is continually evolving as technology advances and healthcare practices adapt to changing needs. As a result, CDSS plays a crucial role in improving patient care, reducing medical errors, enhancing clinical efficiency, and supporting evidence-based medicine. Its potential to positively impact healthcare delivery and patient outcomes makes it an integral part of modern healthcare systems.

The growth of the CDSS market is being driven by advancements in Artificial Intelligence (AI) and Machine Learning (Ml). These transformative technologies are augmenting the capabilities of CDSS by enabling the analysis of extensive healthcare data, thereby furnishing more personalized and predictive recommendations. Furthermore, the integration of CDSS with Electronic Health Record (EHR) systems is becoming increasingly seamless. This integration facilitates immediate access to patient data and clinical decision support at the point of care, rendering it an indispensable tool for healthcare providers. However, the high installation costs associated with CDSS solutions pose a challenge to market growth. Nevertheless, despite these challenges, recent developments such as the emergence of cloud computing and a substantial surge in the adoption of various forms of CDSS by hospitals and healthcare facilities offer promising growth prospects in the near future. Moreover, the increasing initiatives undertaken by governments, aimed at reforming the healthcare sector, are anticipated to create fresh opportunities for the market in the coming years.

Clinical Decision Support Systems Market Size, Share | IGR

In terms of geographical distribution, North America is poised to command a dominant share in the forthcoming forecast period. This is primarily due to the well-established and advanced healthcare infrastructure in North America, particularly in the United States and Canada. The region boasts a substantial number of hospitals, clinics, and healthcare facilities that are readily capable of adopting and seamlessly integrating CDSS into their operational workflows. Furthermore, North America stands as a global epicenter for technology innovation, continually producing cutting-edge healthcare technologies. North American companies and research institutions are at the forefront of CDSS solution development, capitalizing on the latest breakthroughs in artificial intelligence, machine learning, and data analytics. Additionally, the robust regulatory frameworks in North America governing healthcare technologies, including CDSS, provide a clear and compliant pathway for CDSS developers, instilling confidence within the market. Meanwhile, in Asia-Pacific, the CDSS market is experiencing the fastest growth. Several countries in the APAC region are observing an upswing in healthcare expenditure, driven by both government and private investments aimed at enhancing patient care and healthcare outcomes. These investments encompass the adoption of CDSS solutions. The APAC region's CDSS market benefits from various factors, including increasing healthcare investments, a rising demand for advanced healthcare solutions, strong government support, and the region's technological capabilities, positioning it as a fertile ground for substantial CDSS market expansion.

Report Scope of the Clinical Decision Support Systems Market:

Report Coverage Details
Market Size in 2022 USD 4.43 Billion
Market Size by 2030 USD 10.97 Billion
Growth Rate from 2023 to 2030 CAGR of 10.42%
Largest Market North America
No. of Pages 350
Market Drivers
  • The growth of the CDSS market is being driven by advancements in Artificial Intelligence (AI) and Machine Learning.

  • Surging demand for Electronic Health Records (EHR) integration fuels the market growth.

Market Segmentation By System, By Mode of Advice, By Application, By Delivery Model, and By End-use
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment Covered

The report on global clinical decision support systems market covers segments such as system, mode of advice, application, delivery model, and end-use. On the basis of system, the sub-markets include knowledge-based systems, expert laboratory information system, and machine learning systems. On the basis of mode of advice, the sub-markets include passive CDSS, and active CDSS. On the basis of application, the sub-markets include drug databases, care plans, disease reference, and others. On the basis of delivery model, the sub-markets include on-premise, web-based, and cloud-based. On the basis of end-use, the sub-markets include diagnostic centers, hospitals, clinics, retail pharmacy, and diagnostic decision support.

Companies Profiled:

The report provides profiles of the companies in the market such as MCKESSON CORPORATION, Koninklijke Philips N.V., Oracle Cerner, Siemens Healthcare GmbH, Wolters Kluwer N.V., Hearst Communications, Inc., Elsevier, Medical Information Technology, Inc., NextGen Healthcare, Inc., and Epic Systems Corporation.

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the clinical decision support systems market. Moreover, the study highlights current market trends and provides forecasts from 2023-2030. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Frequently Asked Questions (FAQ's)

The global clinical decision support systems market was valued at USD 4.43 Billion in 2022.
It is likely to grow at a CAGR of 10.42% during the forecast period 2023-2030.
The global clinical decision support systems market is estimated to reach USD 10.97 Billion by the end of 2030.
North America is anticipated to exhibit high demand for clinical decision support systems market during the forecast period.
MCKESSON CORPORATION, Koninklijke Philips N.V., Oracle Cerner, Siemens Healthcare GmbH, Wolters Kluwer N.V., Hearst Communications, Inc., Elsevier, Medical Information Technology, Inc., NextGen Healthcare, Inc., and Epic Systems Corporation.
CHOOSE LICENCE TYPE

Please Choose One of them.

Google translate
© 2024. Infinium Global Research LLP. All Rights Reserved.